Press Releases

Dr. Maria Mitchell of AMDeC to Address New York Biotechnology Association
May 12, 2008
 
Document Type: Adobe PDF

[ Return to Top ]

AMDeC selects Taconic for Shared-Use Mouse Facility
January 23, 2008
 
Document Type: Adobe PDF

[ Return to Top ]

AMDeC to host NYAMR
October 22, 2007
 
Document Type: Adobe PDF

[ Return to Top ]

John Whitehead joins AMDeC as Co-Chair
October 22, 2007
 
Document Type: Adobe PDF

[ Return to Top ]

Planning Process Continues for Diabetes/HIT Pilot Project
February 19, 2007
AMDeC is engaged in a planning process for a state-of-the-art pilot project involving the use of HIT tools to accelerate translational research.
Document Type: Adobe PDF

[ Return to Top ]

ROAD Program Links Study of Type 2 Diabetes Risk Factors with Multi-ethnic School-Based Intervention
February 19, 2007
AMDeC’s Reduce Obesity and Diabetes (ROAD) program is a five year study funded with the support of the Starr Foundation to address the molecular physiology of type II diabetes, coupled with a multi-ethnic school based intervention aimed at reversing the growth of obesity and type II diabetes in adolescents.
Document Type: Adobe PDF

[ Return to Top ]

AMDeC's Mouse House
September 25, 2006
New York’s genetic research community is running out of space to house experimental mice; New shared-use “Mouse House” will end shortage, reduce research costs and attract scientific talent and federal research funds to New York
Document Type: Adobe PDF

[ Return to Top ]

What's New at AMDeC
March 14, 2005

AMDeC President, Maria K. Mitchell, Quoted in Newsday Article on

Stem Cell Research

The article reported on newly proposed legislation to fund stem cell research in New York State. AMDeC played a key role in organizing the press conference for Speaker Silver and the Office of the State Comptroller to unveil the new legislation and announce the Comptroller’s release of a report underscoring the importance of state investment in biotechnology and stem cell research. Dr. Mitchell expressed the importance of funding research in the state to retain scientists and build expertise in the region. Lawmakers seek $100M for stem cell research, March 2, 2005.

 

AMDeC Helps Facilitate Lobby Day on Stem Cell Research in Albany

AMDeC, as a leading component of New Yorker’s for the Advancement of Medical Research (NYAMR), worked to facilitate a lobby day in support of stem cell research in New York State. AMDeC spearheaded the formation of the NYAMR coalition two years ago in 2003, and has continued to work with the group to pass pro-stem cell legislation. March 1, 2005

 

AMDeC Cited in Comptroller Alan Hevesi’s Report: The Economic Impact of the Biotechnology and Pharmaceutical Industries in New York

The report discusses the importance of investing in biotechnology, noting that the industry generated $18.1 billion in economic activity in New York State in 2003 and employed over 54,000 people. The report also highlights AMDeC’s role in supporting biotechnology and advancing biomedical research. State Comptroller’s Report  State Comptroller’s Press Release February, 2005

 

AMDeC’s New York Cancer Project Publishes in Ethnicity and Disease

David Vlahov, PhD; Jennifer Ahern, MS; Tara Vazquez, BS; Stephen Johnson, PhD; Laura A. Philips, PhD; Denis Nash, PhD; Maria K. Mitchell, PhD; Harold Freeman, MD. 2005. Racial/ethnic differences in screening for colon cancer: Report from the New York Cancer Project. Ethn Dis. 2005;15(1):76-83. Read the abstract. February, 2005

 

State Senator Kemp Hannon Awards AMDeC $225,000 to Help Kids Fight Obesity
This grant has been awarded to fund an Obesity Intervention Program in schools which aims to reduce obesity in children and consequently improve their long term health and well-being.
The program is unique in that it combines a rigorous scientific research study that will collect and analyze medical, psychological, and biological data with intervention measures, such as an exercise program and school-based nutrition campaign. The grant will fund a pilot program that will provide leverage for the additional funding necessary to implement the program at multiple sites for several years. November, 2004

 

AMDeC receives $500,000 in funding for its Communications Core from NYC Council Speaker Gifford Miller
AMDeC will utilize the funds to build a one-stop-shop portal for the New York biomedical community’s communications needs. Read more about the Communications Core on our AMDeC Initiatives and Core Research Facilities pages. August, 2004

AMDeC’s New York Cancer Project Publishes in Journal of Urban Health
Mitchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. and Vlahov, D. for the New York Cancer Project. 2004. The New York Cancer Project: Rationale, Organization, Design, and Baseline Characteristics Vol. 81, No. 2. Read the abstract. June 1, 2004

AMDeC’s Shared Use Mouse Facility Featured in the Wall Street Journal
The Wall Street Journal reported on the New York region’s need for a mouse facility and the efforts of a number of AMDeC’s members in building one. January 15, 2004

AMDeC Is Instrumental in Building Northeast Biodefense Consortium
The Consortium has received a multi-year grant at more than $9 million per year from the Department of Health and Human Services, in order to establish one of eight Regional Centers of Excellence for Biodefense and Emerging Infectious Disease Research. Read more at our member site: The Wadsworth Center, New York State Department of Health.

September 5, 2003

Newsletter Archive


Document Type: Adobe PDF

[ Return to Top ]

Ambion, Inc. and AMDeC have announced a multi-year alliance agreement to give AMDeC-affiliated institutions access to innovative molecular biology products.
May 14, 2003
Austin, TX and New York, NY — May 7, 2003 — Ambion, Inc. (Austin, TX) and AMDeC LLC (New York, NY) have announced that Ambion has entered into a multi-year alliance agreement with AMDeC, a consortium of 39 of New York State’s medical schools, academic health centers, and research institutions. This alliance between Ambion and AMDeC will give AMDeC-affiliated institutions access to innovative molecular biology products.
Document Type: MS Word

[ Return to Top ]

Sheldon Silver, Speaker of the New York State Assembly, Announces Trail-Blazing Legislation Supporting Stem Cell Research
March 28, 2003
During AMDeC’s 2003 conference on the opportunities for major medical breakthroughs presented by genetic and stem cell research, New York State Assembly Speaker Sheldon Silver – joined by well-known actor/director/activist Christopher Reeve – announced passage of legislation (A06249) that permits and encourages somatic cell nuclear transfer (therapeutic cloning) and other types of research involving stem cells, while banning reproductive cloning. The bill also calls for the creation of a legislative commission on human cloning. Please click on the title above to read the entire release. 
Document Type: MS Word

[ Return to Top ]

LOW RATE OF COLON CANCER SCREENING CONTRIBUTES TO 1500 COLON CANCER DEATHS IN NEW YORK CITY
March 28, 2003
Colon cancer screening rates in New York City are disturbingly low, especially among African Americans, according to two new studies by the New York City Department of Health and Mental Hygiene (DOHMH), and The New York Academy of Medicine (NYAM) in partnership with AMDeC’s New York Cancer Project. Colon cancer, which attacks the colon and/or rectum, is the second leading cause of cancer-related death in the United States. Even though the disease is preventable, colon cancer killed more than 1,500 New Yorkers in 2002 claiming the lives of more non-smokers than any other cancer. Please click on the title above to read the entire release. 
Document Type: MS Word

[ Return to Top ]

BD Biosciences Clontech Selected as Key Supplier of Microarray and PCR Products to AMDeC
January 21, 2003
BD Biosciences Clontech has entered into a multi-year alliance agreement with AMDeC, offering affiliated-institutions including those involved with AMDeC’s Microarray Resource Center access to several technology platforms from BD Biosciences Clontech, including BD Atlas™ Microarrays, BD Advantage™ and BD TITANIUM™ PCR Systems, and BD Sprint™ Lyophililzed PCR Products. Click on the title above to read the full press release.
Document Type: Adobe PDF

[ Return to Top ]

PerkinElmer Selected as Supplier of Cyanine- and Biotin-Labeled Nucleotides to New York’s AMDeC Foundation
November 15, 2002
PerkinElmer Life and Analytical Sciences, a leading provider of drug discovery, life science research, laboratory tools and genetic disease screening solutions, today announced it has been selected by AMDeC Foundation, Inc. to supply key nonradioactive-labeled nucleotides for its affiliated institutions at a significant savings.
Document Type: MS Word

[ Return to Top ]

IOBION ANNOUNCES AMDeC’s ADOPTION OF GENETRAFFIC SOFTWARE PLATFORM
October 7, 2002
Iobion Informatics announced today that AMDeC Foundation, Inc., a consortium of thirty-nine of New York’s world-renowned medical schools, academic health centers, and other research institutions, has adopted GeneTraffic. This deal enables AMDeC affiliated researchers to analyze and share data across institutions, ultimately leading to larger collaborative projects and standardized research protocols. Iobion’s GeneTraffic software stores raw microarray data files, which includes numerical and image files, provides built-in data management, and facilitates data validation and analysis. AMDeC’s microarray resource center, run by Dr. Andrew Brooks of the University of Rochester, will use GeneTraffic Multi as their platform of choice for its combined capability of handling microarray data from Affymetrix® GeneChip® and spotted array experiments.
Document Type: MS Word

[ Return to Top ]

Former NYC Health Commissioner Dr. Neal L. Cohen to Lead AMDeC’s Center on Bioterrorism
September 23, 2002
Former NYC Health Commissioner Dr. Neal L. Cohen to Lead AMDeC’s Center on Bioterrorism
Document Type: MS Word

[ Return to Top ]

CELERA GENOMICS TO PROVIDE DATABASE SUBSCRIPTION TO AMDEC
March 1, 2001
Celera Genomics (NYSE: CRA), an Applera Corporation business, announced today it signed a multi-year agreement with AMDeC LLC. This deal allows AMDeC member institutions to access Celera's database information through its Celera Discovery System™. The Celera Discovery System is an integrated, web-based discovery system that allows subscribers to use Celera generated databases, additional non-proprietary genome and biological datasets, computational tools and super-computing power to advance the discovery programs of researchers worldwide. Click on title to view press release.
Document Type: MS Word

[ Return to Top ]

NEW YORK CANCER PROJECT LAUNCHED; ONE OF THE LARGEST MEDICAL STUDIES EVER UNDERTAKEN IN THE U.S.
October 17, 2000
The New York Cancer Project, one of the largest medical research studies ever undertaken in the United States, was officially launched today by AMDeC. The New York Cancer Project intends to recruit 300,000 New Yorkers aged 30 to 69 from a diverse array of ethnic backgrounds to examine, over a 20-year period, the interplay of genetic, environmental, and lifestyle factors in the incidence of cancer. Cancer will soon overtake heart disease as the leading cause of premature death in America. The New York Cancer Project is the first major research collaboration undertaken by AMDeC. Researchers believe that the Cancer Project will provide special insight into the incidence of cancer among New Yorkers of diverse ethnic backgrounds, including those of African-American, Caribbean, Chinese, Dominican, Irish, Italian, Puerto Rican, and Russian extraction, as well as Ashkenazi Jews.  
Document Type: MS Word

[ Return to Top ]

PIONEERING TECHNIQUE TO SCREEN LUNG CANCER AT EARLY, MOST TREATABLE STAGE TO BE TESTED IN LARGE-SCALE STUDY SPONSORED BY AMDEC
August 21, 2000
At a City Hall news conference today, New York City Mayor Rudolph Giuliani joined Dr. Maria K. Mitchell, President and CEO of AMDeC, Dr. Michael A. Stocker, President and Chief Executive Officer of Empire Blue Cross and Blue Shield, and Dr. Antonio M. Gotto, Jr., Dean of the Joan and Sanford I. Weill Medical College of Cornell University to announce the commencement of a large-scale study examining the promise of CT (computerized tomography) scanning in diagnosing lung cancer at its earliest and most treatable stages.

The study – the New York Early Lung Cancer Action Program (NY-ELCAP) – will screen 10,000 New Yorkers who are heavy or former smokers to confirm the findings of a pilot project conducted at the Weill Cornell Medical Center of New York-Presbyterian Hospital, and set the stage for broader use of this technique.  
Document Type: MS Word

[ Return to Top ]

Grants Support Young Scientists in Research on Breast and Ovarian Cancer
April 10, 2000
AMDeC awarded three scientists grants from its Tartikoff/Perelman/EIF Fund for Young Investigators to research promising new strategies for the detection and treatment of breast, ovarian, and other cancers. These awards represent the second round of grants established through proceeds of the Revlon Run/Walk for Women, held annually in New York City.
Document Type: MS Word

[ Return to Top ]

AMDeC and Affymetrix Sign Academic Access Preferred Agreement
April 5, 2000
AMDeC and Affymetrix, makers of genechip technology, entered into an agreement enabling AMDeC participating institutions widespread access to Affymetrix' standard and custom Genechip arrays, instrumentation and software to monitor gene expression for use in their research and development activities. This agreement marks the first time the New York research community collectively leveraged its purchasing power to take advantage of a business arrangement to further their biomedical research efforts.
Document Type: MS Word

[ Return to Top ]